RB Global and Amgen Raise 2026 Financial Outlooks

RB Global has raised its 2026 outlook for Gross Transaction Value (GTV) growth to 9%-11%, partly due to the addition of BigIron. Amgen also increased its 2026 EPS and revenue guidance after beating Q2 expectations.